drugset / Trial / NCT00708578

Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)

NCT00708578

Phase 4 Completed 99 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

Primary objective: To find out an optimal regimen of OHA (oral hypoglycaemic agents) in combination with insulin glargine (metformin, glimepiride or metformin+glimepiride) by measuring HbA1c level Secondary objective: To compare the incidence of hypoglycemia in each treatment group

Timeline

Start
2008-05
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Glimepiride Small molecule 4 mg Oral
Subject Metformin Small molecule 1000 mg Oral
Subject Metformin Small molecule 1500 mg Oral
Subject insulin glargine Protein / enzyme biologic Other